Jene Smith
Acute Care · Oxford, MSNPI 1073505418
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 228 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 33.0% of the total. Reporting peaked in 2021 at $1,044 and has fallen 95.2% since, to $50 in 2025.
Across 228 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$304
- Pfizer$186
- Lilly USA, LLC$181
- AstraZeneca$160
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$145
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,478100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 88 | $1,149 |
| Novo Nordisk | 20 | $304 |
| Pfizer | 10 | $186 |
| Lilly USA, LLC | 12 | $181 |
| AstraZeneca | 11 | $160 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $145 |
| Amarin Pharma, Inc. | 9 | $145 |
| Boehringer Ingelheim | 7 | $119 |
| Bausch Health US, LLC | 6 | $107 |
| Nestle Healthcare Nutrition Inc. | 6 | $106 |
| Supernus Pharmaceuticals, Inc. | 4 | $82 |
| Dexcom, Inc. | 5 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| Amgen | 5 | $75 |
| Bayer | 4 | $72 |
| Johnson & Johnson(2 entities) | 3 | $65 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Teva Pharmaceuticals USA, Inc. | 3 | $47 |
| Astellas Pharma US Inc | 2 | $40 |
| Lundbeck LLC | 2 | $33 |
| Idorsia Pharmaceuticals US Inc | 2 | $32 |
| GSK | 2 | $31 |
| Novartis | 2 | $29 |
| Edwards Lifesciences | 1 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$3,478 in reported general payments places this provider in the 85th percentile of 223 acute care providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 20 | $24,259 |
| FarxigaDapagliflozin Propanediol | 18 | $20,337 |
| OzempicSemaglutide | 11 | $19,697 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 11 | $12,347 |
| SynthroidLevothyroxine Sodium | 13 | $1,041 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $974 |
| Ezetimibe | 27 | $667 |
| Rosuvastatin Calcium | 44 | $576 |
| Losartan Potassium | 60 | $564 |
| Duloxetine Hcl | 20 | $526 |
| Pravastatin Sodium | 32 | $398 |
| Gabapentin | 42 | $377 |
| Pantoprazole Sodium | 62 | $366 |
| Telmisartan | 12 | $322 |
| Potassium Chloride | 25 | $320 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $181 | $24,25920 claims |
| AstraZenecaFarxiga | $160 | $20,33718 claims |
| Novo NordiskOzempic | $304 | $19,69711 claims |
| Boehringer IngelheimSynjardy Xr | $119 | $12,34711 claims |
| AbbVieSynthroid | $1,149 | $1,04113 claims |
| Almatica Pharma LLCSertraline Hcl | $17 | $24624 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 223 acute care providers in Mississippi.
Other acute care in Oxford
- Gavin GistOxford$42K
- Sharon UptonOxford$10K
- Raquel VaughanOxford$6K
- Lee FergusonOxford$5K
- Christopher BellTupelo$348K
- Kathleen ArnoldOcean Springs$217K
- Jamie DamicoOcean Springs$17K
- Dylan BoydHattiesburg$15K
- Melinda ClarkStarkville$14K
- Michelle TaylorGulfport$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.